Bradley Herring Sells 24,443 Shares of Enfusion, Inc. (NYSE:ENFN) Stock

Enfusion, Inc. (NYSE:ENFN) CFO Bradley Herring sold 24,443 shares of the stock in a transaction that occurred on Friday, December 20th. The stock was sold at an average price of $10.61, for a total transaction of $259,340.23. Following the completion of the sale, the chief financial officer now owns 270,503 shares of the company’s stock, valued at approximately $2,870,036.83. The trade was a 8.29 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Enfusion Trading Down 5.6 %

Shares of NYSE:ENFN opened at $10.09 on Friday. The stock has a market capitalization of $1.30 billion, a PE ratio of 252.31, a P/E/G ratio of 3.98 and a beta of 0.97. Enfusion, Inc. has a 1 year low of $7.52 and a 1 year high of $11.38. The firm has a fifty day moving average price of $9.87 and a 200 day moving average price of $9.06.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on ENFN. Stifel Nicolaus increased their price objective on Enfusion from $11.00 to $13.00 and gave the stock a “buy” rating in a report on Wednesday, December 18th. Piper Sandler raised their price target on Enfusion from $10.00 to $11.50 and gave the stock a “neutral” rating in a research note on Monday, December 23rd. Three analysts have rated the stock with a sell rating, one has given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $10.25.

Institutional Trading of Enfusion

Several large investors have recently made changes to their positions in the stock. Arizona State Retirement System acquired a new stake in Enfusion in the 2nd quarter worth approximately $86,000. Harbor Capital Advisors Inc. lifted its stake in shares of Enfusion by 12.4% in the third quarter. Harbor Capital Advisors Inc. now owns 11,887 shares of the company’s stock worth $113,000 after buying an additional 1,315 shares during the last quarter. Belvedere Trading LLC bought a new stake in shares of Enfusion during the 3rd quarter worth $114,000. Paloma Partners Management Co acquired a new position in Enfusion in the 3rd quarter valued at $157,000. Finally, The Manufacturers Life Insurance Company raised its holdings in Enfusion by 27.7% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 19,562 shares of the company’s stock worth $167,000 after acquiring an additional 4,239 shares during the period. Institutional investors own 81.05% of the company’s stock.

Enfusion Company Profile

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.